Delivering Personalized Medicine: Focus on Pharmacogenomics, Medication Optimization and Collaborative Care Models to Enhance Patient Outcomes & Topics in Gastroenterology
Delivering Personalized Medicine: Focus on Pharmacogenomics, Medication Optimization and Collaborative Care Models to Enhance Patient Outcomes & Topics in Gastroenterology is organized by Continuing Education Inc and will be held from Aug 15 - 22, 2021 at Holland America's Oosterdam, Seattle, Washington, United States of America.
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists
Credit Designation for Physicians: Continuing Education, Inc. designates this live activity for 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation for Nurses:
Continuiung Education, Inc. designates this continuing nursing education activity for 16 contact hours.
Credit Designation for Pharmacists:
This knowledge-based activity is approved for 16 hours of pharmacy continuing education credit.
The purpose of these lectures is to review and update knowledge on the mechanisms and pathogenesis, new developments in the diagnosis, treatment, and guidelines for important diseases involving the gastrointestinal tract and liver. Lectures will cover epidemiology, risk factors, clinical pearls, new methodology, imaging, and evidence-based recommendations to allow the audience to determine how best to alter clinical practices to improve health care team performance and outcomes with regards to digestive diseases.
• Celiac Disease
Identify risk factors, symptoms, signs, tests, treatment for celiac disease
• C. difficile colitis
Define risk factors, symptoms, signs, tests, treatment for C. difficile colitis
• Eosinophilic esophagitis
Describe risk factors, symptoms, signs, tests, treatment for eosinophilic
• Fulminant hepatic failure
Cite risk factors, symptoms, signs, tests, treatment for fulminant hepatic failure
• Update, chronic hepatitis C
Identify risk factors, symptoms, signs, tests, treatment for chronic hepatitis C
• Non-alcoholic fatty liver disease
Define risk factors, symptoms, signs, tests, treatment for non-alcoholic fatty liver disease
• Cirrhosis and complications
Identify risk factors, symptoms, signs, tests, treatment for cirrhosis and complications
• Biliary Obstruction
Describe risk factors, symptoms, signs, tests, treatment for biliary obstruction
• Recognize the evolving role pharmacogenomics is playing in the delivery of personalized medicine.
Describe common sources for medication-related miscommunications and how poor medication adherence can impact the clinical and economic outcomes for patient, providers, and stakeholders.
Discuss the rationale for collaborative models of care that deliver enhanced clinical, patient, and economic outcomes.
• From Pharmacogenomics to Personalized Medicine
Identify new personal health care technologies and the impact they may have on patient outcomes.
• Optimizing Medication Adherence and Outcomes
Create strategies to promote medications adherence among all healthcare providers.
Describe the impact of poor adherence on clinical and economic outcomes for patient and stakeholders.
• Comprehensive Medication Management Services
Outline the value of leveraging the prescription benefit to reduce downstream healthcare costs and outcomes.
- CME : 16
- Contact Hours : 16
- Credit : 16
- Hours : 16
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Immunology and Microbiology
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine